|
|
Volumn 326, Issue 5950, 2009, Pages 218-220
|
|
Looking for a target on every tumor
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B RAF KINASE;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
GEFITINIB;
HYBRID PROTEIN;
IMATINIB;
MITOGEN ACTIVATED PROTEIN KINASE KINASE 1;
PROTEIN EML4 ALK;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
DRUG DEVELOPMENT;
DRUG RESISTANCE;
GENETIC ANALYSIS;
MUTATION;
RESEARCH WORK;
TUMOR;
ADVANCED CANCER;
BREAST CANCER;
CANCER CENTER;
CANCER RESEARCH;
CANCER SUSCEPTIBILITY;
CHRONIC MYELOID LEUKEMIA;
COLORECTAL CANCER;
DRUG MECHANISM;
FOOD AND DRUG ADMINISTRATION;
GENE EXPRESSION;
GENE MUTATION;
GENE OVEREXPRESSION;
GENE SEQUENCE;
GENETIC ANALYSIS;
GENOTYPE;
HUMAN;
LUNG ADENOCARCINOMA;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
ONCOGENE K RAS;
PRIORITY JOURNAL;
SHORT SURVEY;
TUMOR BIOPSY;
TUMOR GROWTH;
CLASSIFICATION;
CLINICAL TRIAL;
GENETIC SCREENING;
GENETICS;
MUTATION;
NEOPLASM;
NOTE;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
GENETIC SCREENING;
GENOTYPE;
HUMANS;
MUTATION;
NEOPLASMS;
|
|
EID: 70349863393
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.326_218 Document Type: Short Survey |
|
Times cited : (14)
|
|
References (0)
|